Similar study performed on mouse xenograft model demonstrated that SIRT1 inhibition by EX257 enhances the sensitivity of HPV+ head and neck cancer cells to genotoxic agents, including cisplatin47, showing that EX257 display similar activity against different cancer types in vivo, and not restricted to BC only. The gene discussed is SIRT1; the disease is head and neck cancer.